Mallinckrodt, drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits, report says
Mallinckrodt said the report that it was seeking to leverage the Purdue bankruptcy was "completely unfounded."
Mallinckrodt said the report that it was seeking to leverage the Purdue bankruptcy was "completely unfounded."